TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2012

Efficacy and safety of regorafenib in patients with metastatic and/or unresectable GI stromal tumor after failure of imatinib and sunitinib: a multicenter phase II trial.

Suzanne George et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.